Darryl J Fisher, MD | |
201 E Pomona Ave, Monrovia, CA 91016-4639 | |
(626) 660-5678 | |
Not Available |
Full Name | Darryl J Fisher |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Experience | 44 Years |
Location | 201 E Pomona Ave, Monrovia, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1184718769 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | G45490 (California) | Primary |
207P00000X | Emergency Medicine | MD2009-0233 (New Mexico) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Rehoboth Mckinley Christian Health Care Services | Gallup, NM | Hospital |
Colorado River Medical Center | Needles, CA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Community Healthcare Partner, Inc | 5698912095 | 5 |
Emergency Staffing Solutions Inc | 9830001650 | 28 |
News Archive
Cataracts, a clouding of the lens in the eye leading to vision loss, affects more than 24 million people in the United States, according to National Institutes of Health estimates. Often linked to the natural process of aging, cataracts are a major cause of blindness worldwide. K. Krishna Sharma, an ophthalmology researcher at the University of Missouri, has worked for more than two decades to study the mechanisms involved in this degenerative disease.
Breast Cancer Action - respected watchdog of the breast cancer movement - is calling out money-making giants KFC and Susan G. Komen for the Cure for their egregious pinkwashing campaign "Buckets for the Cure." This partnership exploits breast cancer and does the most harm in low income communities already disproportionately affected by health issues like obesity, diabetes, as well as breast cancer.
In January 2012, the OAC and Obesity PPM will launch a long-term online educational initiative to increase understanding of the complexity of obesity and its many causes. The disease of obesity impacts individuals physically, emotionally, economically and socially. This initiative will look at various factors, both controllable and uncontrollable, impacting individuals affected by obesity.
Researchers at the Technion-Israel Institute of Technology and their partners at Bar Ilan University have developed new technology to inhibit the development of Alzheimer's disease.
FibroGen, Inc., today announced that new data from a phase 2a study of patients with stage 3-4 Chronic Kidney Disease and anemia will be presented demonstrating that its first-in-class, investigational oral anemia therapy FG-4592 works differently than erythropoiesis stimulating agents (ESAs) to increase hemoglobin.
› Verified 8 days ago
Entity Name | Riverside Emergency Physicians Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1972539039 PECOS PAC ID: 0547173882 Enrollment ID: O20040729001307 |
News Archive
Cataracts, a clouding of the lens in the eye leading to vision loss, affects more than 24 million people in the United States, according to National Institutes of Health estimates. Often linked to the natural process of aging, cataracts are a major cause of blindness worldwide. K. Krishna Sharma, an ophthalmology researcher at the University of Missouri, has worked for more than two decades to study the mechanisms involved in this degenerative disease.
Breast Cancer Action - respected watchdog of the breast cancer movement - is calling out money-making giants KFC and Susan G. Komen for the Cure for their egregious pinkwashing campaign "Buckets for the Cure." This partnership exploits breast cancer and does the most harm in low income communities already disproportionately affected by health issues like obesity, diabetes, as well as breast cancer.
In January 2012, the OAC and Obesity PPM will launch a long-term online educational initiative to increase understanding of the complexity of obesity and its many causes. The disease of obesity impacts individuals physically, emotionally, economically and socially. This initiative will look at various factors, both controllable and uncontrollable, impacting individuals affected by obesity.
Researchers at the Technion-Israel Institute of Technology and their partners at Bar Ilan University have developed new technology to inhibit the development of Alzheimer's disease.
FibroGen, Inc., today announced that new data from a phase 2a study of patients with stage 3-4 Chronic Kidney Disease and anemia will be presented demonstrating that its first-in-class, investigational oral anemia therapy FG-4592 works differently than erythropoiesis stimulating agents (ESAs) to increase hemoglobin.
› Verified 8 days ago
Entity Name | Apex Emergency Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1265711089 PECOS PAC ID: 4688844277 Enrollment ID: O20110909002790 |
News Archive
Cataracts, a clouding of the lens in the eye leading to vision loss, affects more than 24 million people in the United States, according to National Institutes of Health estimates. Often linked to the natural process of aging, cataracts are a major cause of blindness worldwide. K. Krishna Sharma, an ophthalmology researcher at the University of Missouri, has worked for more than two decades to study the mechanisms involved in this degenerative disease.
Breast Cancer Action - respected watchdog of the breast cancer movement - is calling out money-making giants KFC and Susan G. Komen for the Cure for their egregious pinkwashing campaign "Buckets for the Cure." This partnership exploits breast cancer and does the most harm in low income communities already disproportionately affected by health issues like obesity, diabetes, as well as breast cancer.
In January 2012, the OAC and Obesity PPM will launch a long-term online educational initiative to increase understanding of the complexity of obesity and its many causes. The disease of obesity impacts individuals physically, emotionally, economically and socially. This initiative will look at various factors, both controllable and uncontrollable, impacting individuals affected by obesity.
Researchers at the Technion-Israel Institute of Technology and their partners at Bar Ilan University have developed new technology to inhibit the development of Alzheimer's disease.
FibroGen, Inc., today announced that new data from a phase 2a study of patients with stage 3-4 Chronic Kidney Disease and anemia will be presented demonstrating that its first-in-class, investigational oral anemia therapy FG-4592 works differently than erythropoiesis stimulating agents (ESAs) to increase hemoglobin.
› Verified 8 days ago
Entity Name | Community Healthcare Partner, Inc |
---|---|
Entity Type | Part A Provider - Critical Access Hospital |
Entity Identifiers | NPI Number: 1457520942 PECOS PAC ID: 5698912095 Enrollment ID: O20130502000053 |
News Archive
Cataracts, a clouding of the lens in the eye leading to vision loss, affects more than 24 million people in the United States, according to National Institutes of Health estimates. Often linked to the natural process of aging, cataracts are a major cause of blindness worldwide. K. Krishna Sharma, an ophthalmology researcher at the University of Missouri, has worked for more than two decades to study the mechanisms involved in this degenerative disease.
Breast Cancer Action - respected watchdog of the breast cancer movement - is calling out money-making giants KFC and Susan G. Komen for the Cure for their egregious pinkwashing campaign "Buckets for the Cure." This partnership exploits breast cancer and does the most harm in low income communities already disproportionately affected by health issues like obesity, diabetes, as well as breast cancer.
In January 2012, the OAC and Obesity PPM will launch a long-term online educational initiative to increase understanding of the complexity of obesity and its many causes. The disease of obesity impacts individuals physically, emotionally, economically and socially. This initiative will look at various factors, both controllable and uncontrollable, impacting individuals affected by obesity.
Researchers at the Technion-Israel Institute of Technology and their partners at Bar Ilan University have developed new technology to inhibit the development of Alzheimer's disease.
FibroGen, Inc., today announced that new data from a phase 2a study of patients with stage 3-4 Chronic Kidney Disease and anemia will be presented demonstrating that its first-in-class, investigational oral anemia therapy FG-4592 works differently than erythropoiesis stimulating agents (ESAs) to increase hemoglobin.
› Verified 8 days ago
Entity Name | Community Healthcare Partner, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1457520942 PECOS PAC ID: 5698912095 Enrollment ID: O20140113000061 |
News Archive
Cataracts, a clouding of the lens in the eye leading to vision loss, affects more than 24 million people in the United States, according to National Institutes of Health estimates. Often linked to the natural process of aging, cataracts are a major cause of blindness worldwide. K. Krishna Sharma, an ophthalmology researcher at the University of Missouri, has worked for more than two decades to study the mechanisms involved in this degenerative disease.
Breast Cancer Action - respected watchdog of the breast cancer movement - is calling out money-making giants KFC and Susan G. Komen for the Cure for their egregious pinkwashing campaign "Buckets for the Cure." This partnership exploits breast cancer and does the most harm in low income communities already disproportionately affected by health issues like obesity, diabetes, as well as breast cancer.
In January 2012, the OAC and Obesity PPM will launch a long-term online educational initiative to increase understanding of the complexity of obesity and its many causes. The disease of obesity impacts individuals physically, emotionally, economically and socially. This initiative will look at various factors, both controllable and uncontrollable, impacting individuals affected by obesity.
Researchers at the Technion-Israel Institute of Technology and their partners at Bar Ilan University have developed new technology to inhibit the development of Alzheimer's disease.
FibroGen, Inc., today announced that new data from a phase 2a study of patients with stage 3-4 Chronic Kidney Disease and anemia will be presented demonstrating that its first-in-class, investigational oral anemia therapy FG-4592 works differently than erythropoiesis stimulating agents (ESAs) to increase hemoglobin.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Darryl J Fisher, MD 201 E Pomona Ave, Monrovia, CA 91016-4639 Ph: (626) 660-5678 | Darryl J Fisher, MD 201 E Pomona Ave, Monrovia, CA 91016-4639 Ph: (626) 660-5678 |
News Archive
Cataracts, a clouding of the lens in the eye leading to vision loss, affects more than 24 million people in the United States, according to National Institutes of Health estimates. Often linked to the natural process of aging, cataracts are a major cause of blindness worldwide. K. Krishna Sharma, an ophthalmology researcher at the University of Missouri, has worked for more than two decades to study the mechanisms involved in this degenerative disease.
Breast Cancer Action - respected watchdog of the breast cancer movement - is calling out money-making giants KFC and Susan G. Komen for the Cure for their egregious pinkwashing campaign "Buckets for the Cure." This partnership exploits breast cancer and does the most harm in low income communities already disproportionately affected by health issues like obesity, diabetes, as well as breast cancer.
In January 2012, the OAC and Obesity PPM will launch a long-term online educational initiative to increase understanding of the complexity of obesity and its many causes. The disease of obesity impacts individuals physically, emotionally, economically and socially. This initiative will look at various factors, both controllable and uncontrollable, impacting individuals affected by obesity.
Researchers at the Technion-Israel Institute of Technology and their partners at Bar Ilan University have developed new technology to inhibit the development of Alzheimer's disease.
FibroGen, Inc., today announced that new data from a phase 2a study of patients with stage 3-4 Chronic Kidney Disease and anemia will be presented demonstrating that its first-in-class, investigational oral anemia therapy FG-4592 works differently than erythropoiesis stimulating agents (ESAs) to increase hemoglobin.
› Verified 8 days ago